Novartis Loses Challenge to Block Biden Drug Price Negotiations

Novartis AG’s bid to block the US government’s drug price negotiation plan was rejected by a federal judge in another win for the Biden administration as it continues to roll out its landmark program.

Judge Zahid N. Quraishi of the US District Court for the District of New Jersey on Friday ruled against Novartis’ claims that the Medicare Drug Price Negotiation Program takes property, compels speech, and violates the excessive fines clause.

Quraishi’s decision adds to President Joe Biden’s victories in defending his Medicare Drug Price Negotiation Program, which was created under the Inflation Reduction Act to slash the ...